new study showing coenzyme Q10 might slow progression of Parkinson's disease
November 2002
Patients are asking about the new study showing coenzyme Q10 might slow progression of Parkinson's disease.
Researchers suspect that coenzyme Q10 improves energy production in the mitochondria. Parkinson's patients seem to have lower levels of CoQ10 and reduced mitochondrial function.
CoQ10 is also a potent antioxidant that might protect brain cells.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive